Factors influencing the occurrence of secondary malignancies in high-risk lymphoma patients following high-dose therapy and autograft

MLA

Tarella C, et al. Factors Influencing the Occurrence of Secondary Malignancies in High-Risk Lymphoma Patients Following High-Dose Therapy and Autograft. Jan. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.....10495..25091efd41f92597395d97820f1d0406&authtype=sso&custid=ns315887.

APA

Tarella C, Passera R, Magni M, Rossi A, Benedetti F, Gueli A, Ruella M, Patti C, Parvis G, Gallamini A, Cortelazzo S, Corradini P, Zoli V, Mule A, Crocchiolo R, Bosa M, Barbui A, Di Nicola M, Caracciolo D, … Ciceri. (2010). Factors influencing the occurrence of secondary malignancies in high-risk lymphoma patients following high-dose therapy and autograft.

Chicago

Tarella C, Passera R, Magni M, Rossi A, Benedetti F, Gueli A, Ruella M, et al. 2010. “Factors Influencing the Occurrence of Secondary Malignancies in High-Risk Lymphoma Patients Following High-Dose Therapy and Autograft,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.....10495..25091efd41f92597395d97820f1d0406&authtype=sso&custid=ns315887.